Executive summary: Regional anesthesia in the patient receiving antithrombotic or thrombolytic therapy: American society of regional anesthesia and pain medicine evidence-based guidelines (Third Edition)

Regional Anesthesia and Pain Medicine

Volumn 35, Issue 1, 2010, Pages 102-105

  Horlocker, Terese T ^a   Wedel, Denise J ^a   Rowlingson, John C ^b   Enneking, F Kayser ^c  

^a MAYO CLINIC   (United States)

^b UNIVERSITY OF VIRGINIA HEALTH SYSTEM   (United States)

^c UNIVERSITY OF FLORIDA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ABCIXIMAB; ACETYLSALICYLIC ACID; ANTICOAGULANT AGENT; ANTITHROMBOCYTIC AGENT; ARGATROBAN; BLOOD CLOTTING FACTOR 10; BLOOD CLOTTING FACTOR 10A ANTIBODY; BLOOD CLOTTING FACTOR 7; BLOOD CLOTTING FACTOR 9; CLOPIDOGREL; CYCLOOXYGENASE 2 INHIBITOR; DALTEPARIN; DESULFATOHIRUDIN; ENOXAPARIN; EPTIFIBATIDE; FIBRINOLYTIC AGENT; FONDAPARINUX; HEPARIN; HERBACEOUS AGENT; HIRULOG; LEPIRUDIN; LOW MOLECULAR WEIGHT HEPARIN; NONSTEROID ANTIINFLAMMATORY AGENT; PROTEIN ANTIBODY; PROTHROMBIN; TICLOPIDINE; TINZAPARIN; TIROFIBAN; UNCLASSIFIED DRUG; WARFARIN;

ANTIBODY BLOOD LEVEL; ANTICOAGULANT THERAPY; BIRTH; BLEEDING; CATHETER REMOVAL; CONSENSUS; DRUG CONTRAINDICATION; DRUG DOSE REGIMEN; DRUG EFFECT; EPIDURAL ANESTHESIA; EVIDENCE BASED PRACTICE; FIBRINOLYTIC THERAPY; HEMOSTASIS; HEPARIN INDUCED THROMBOCYTOPENIA; HERBAL MEDICINE; HIGH RISK PATIENT; HUMAN; INTERNATIONAL NORMALIZED RATIO; LOW DRUG DOSE; MEDICAL RECORD REVIEW; NERVE BLOCK; PATIENT ASSESSMENT; PATIENT EDUCATION; PATIENT MONITORING; POSTOPERATIVE CARE; PRACTICE GUIDELINE; PREOPERATIVE EVALUATION; PREOPERATIVE TREATMENT; PRIORITY JOURNAL; REGIONAL ANESTHESIA; RISK BENEFIT ANALYSIS; SHORT SURVEY; SPINAL ANESTHESIA; SPINAL HEMATOMA; THROMBOCYTE AGGREGATION; THROMBOSIS; THROMBOSIS PREVENTION; TREATMENT WITHDRAWAL; VENOUS THROMBOEMBOLISM;

ANESTHESIA, CONDUCTION; ANESTHESIOLOGY; ANTICOAGULANTS; EVIDENCE-BASED MEDICINE; FIBRINOLYTIC AGENTS; HEPARIN; HEPARIN, LOW-MOLECULAR-WEIGHT; HUMANS; PLATELET AGGREGATION INHIBITORS; SOCIETIES, MEDICAL; VENOUS THROMBOEMBOLISM;

EID: 74549222257     PISSN: 10987339     EISSN: None     Source Type: Journal    
DOI: 10.1097/AAP.0b013e3181c15dd0     Document Type: Short Survey

References (6)

1. Enneking FK, Benzon H. Oral anticoagulants and regional anesthesia: a perspective. Reg Anesth Pain Med. 1998;23:140-145.
2. Horlocker TT, Wedel DJ. Neuraxial block and low-molecular-weight heparin: balancing perioperative analgesia and thromboprophylaxis. Reg Anesth Pain Med. 1998;23:164-177.
3. Horlocker TT, Wedel DJ, Benzon H, et al. Regional anesthesia in the anticoagulated patient: defining the risks (the second ASRA Consensus Conference on Neuraxial Anesthesia and Anticoagulation). Reg Anesth Pain Med. 2003;28:172-197.
4. Liu SS, Mulroy MF. Neuraxial anesthesia and analgesia in the presence of standard heparin. Reg Anesth Pain Med. 1998;23:157-163.
5. Rosenquist RW, Brown DL. Neuraxial bleeding: fibrinolytics/thrombolytics. Reg Anesth Pain Med. 1998;23:152-156.
6. Urmey WF, Rowlingson J. Do antiplatelet agents contribute to the development of perioperative spinal hematoma? Reg Anesth Pain Med. 1998;23:146-151.